HTEC
ROBO Global Healthcare Technology and Innovation ETF
The ROBO Global Healthcare Technology and Innovation ETF tracks a market-cap selected and weighted index of global healthcare technology companies.
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 51.8 M
ASSETS UNDER MGMT
68 bp
EXPENSES
Fund Basics
| Inception date | Jun 24, 2019 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| ARROWHEAD PHARMACEUTICALS, INC. | 2.1 % |
| SIEMENS HEALTHINEERS AG | 2.0 % |
| THERMO FISHER SCIENTIFIC INC | 2.0 % |
| GUARDANT HEALTH, INC. | 2.0 % |
| VERTEX PHARMACEUTICALS INC | 2.0 % |
| REGENERON PHARMACEUTICALS | 2.0 % |
| AXOGEN, INC. | 2.0 % |
| INTUITIVE SURGICAL INC | 2.0 % |
| BOSTON SCIENTIFIC CORP | 1.9 % |
| ADAPTIVE BIOTECHNOLOGIES CORP. | 1.9 % |
Constituent Breakdown
| Number of holdings | 63 |
| Herfindahl-Hirschman Index | 165 |
| Wgt avg mkt cap (mns) | $39,474 |
| Large cap (>$10bn) | 61.3% |
| Mid cap ($2-10bn) | 20.8% |
| Small cap (<$2bn) | 12.5% |
| Developed mkts. | 97.5% |
| Emerging mkts. | 1.5% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 76.9 % |
 |
SWITZERLAND | 5.0 % |
 |
BRITAIN | 4.8 % |
 |
NETHERLANDS | 3.3 % |
 |
GERMANY | 2.0 % |
 |
LUXEMBOURG | 1.8 % |
 |
CHINA | 1.5 % |
 |
ITALY | 1.3 % |
 |
JAPAN | 1.3 % |
 |
HONG KONG | 1.0 % |
Historical Performance
Standardized Performance (as of 03/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -6.5% | 20.8% | 7.8% | 3.5% | -5.5% | -- | -- | 4.7% |
| Dividend Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -- | -- | 0.0% |
| Total Returns | -6.5% | 20.8% | 7.8% | 3.5% | -5.5% | -- | -- | 4.7% | Ann. Volatility | 22.0% | 23.9% | 21.5% | 20.8% | 24.3% | -- | -- | 25.5% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.96 | 58% |
| MSCI EAFE | 0.97 | 51% |
| MSCI Emg Mkts | 0.73 | 38% |
Liquidity Measures
| Avg. volume (000) | 9 |
| ADV traded (mns) | $0 |
| Turnover | 0.6% |
| Avg. Bid/Ask (% of price) | 0.18% |
Technical Indicators
| 30d moving avg. (EMA) | $33.76 |
| Relative strength (RSI) | 47 |
| MACD/Signal | 0.10/0.05 |
| Bollinger Bands (Upper/Lower) | $35.14/$31.93 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. HTEC |
Expenses vs. HTEC |
ALTAR Score™ vs. HTEC |
|---|---|---|---|---|
| MDEV | First Trust Indxx Medical Devices ETF | 32.6% | +2 bp | +3.0% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 30.7% | -33 bp | +1.5% |
| BMED | Future Health ETF | 29.7% | +17 bp | -1.4% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 29.6% | -28 bp | +4.8% |
| HELX | Franklin Genomic Advancements ETF | 27.8% | -18 bp | -3.4% |
| FXH | First Trust Health Care AlphaDEX Fund | 27.8% | -6 bp | +3.1% |
| FHLC | Fidelity MSCI Health Care Index ETF | 24.3% | -60 bp | +3.5% |
| IYH | iShares U.S. Healthcare ETF | 24.2% | -28 bp | +4.1% |
| FMED | Fidelity Disruptive Medicine ETF | 23.7% | -18 bp | -3.7% |
| VHT | Vanguard Health Care ETF | 23.4% | -59 bp | +3.3% |
Risk and Returns: HTEC vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 5/1/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
2.4%
ALTAR SCORE™
23rd
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 586 funds in the Global Equity category with an average
ALTAR Score™ of 4.3% and a standard deviation
of 2.6%. HTEC's ALTAR Score™ is approximately -0.7 standard
deviations above the category average. This places HTEC in the 23rd percentile
among funds in the category.
Sell-Side Consensus
$42.95
PRICE TARGET
+28.6%
UPSIDE